Rockwell Medical (RMTI) EBIAT (2016 - 2025)
Rockwell Medical (RMTI) has disclosed EBIAT for 16 consecutive years, with -$1.8 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EBIAT fell 205.35% year-over-year to -$1.8 million, compared with a TTM value of -$5.5 million through Sep 2025, down 346.28%, and an annual FY2024 reading of -$480000.0, up 94.31% over the prior year.
- EBIAT was -$1.8 million for Q3 2025 at Rockwell Medical, down from -$1.5 million in the prior quarter.
- Across five years, EBIAT topped out at $1.7 million in Q3 2024 and bottomed at -$8.9 million in Q4 2021.
- Average EBIAT over 5 years is -$3.4 million, with a median of -$1.9 million recorded in 2023.
- The sharpest move saw EBIAT soared 188.89% in 2024, then crashed 534.99% in 2025.
- Year by year, EBIAT stood at -$8.9 million in 2021, then soared by 73.58% to -$2.4 million in 2022, then surged by 35.99% to -$1.5 million in 2023, then soared by 50.0% to -$756000.0 in 2024, then plummeted by 131.88% to -$1.8 million in 2025.
- Business Quant data shows EBIAT for RMTI at -$1.8 million in Q3 2025, -$1.5 million in Q2 2025, and -$1.5 million in Q1 2025.